Intrauterine Device Clinical Trial
Official title:
Cold Compress for Pain Associated With Intrauterine Device Insertion: A Randomized Controlled Trial
This study will be a prospective randomized controlled trial comparing cold compression to no intervention immediately prior to and during intrauterine device insertion. Subjects will be randomized to cold compress or no intervention (standard practice in our clinics). Following IUD insertion they will complete a validated pain scale survey regarding their pre-procedure and intra-procedure pain.
This study will be a prospective randomized controlled trial comparing cold compression to no
intervention immediately prior to and during intrauterine device insertion. Inclusion
criteria include all non-pregnant women, 18 years of age or older, presenting to the VCU
Women's Health clinics with desired IUD placement.
Subjects will be identified at the time of presentation to the Women's Health Clinics at
Virginia Commonwealth University Health Systems. A provider (physician, nurse practioner, or
nurse midwife) will discuss the study with the subject. After time for consideration and
having had all questions answered the subject will then be consented for the trial. Consent
will be obtained at that time (see attached list of engaged providers). Randomization will be
performed by pulling sequentially numbered opaque envelopes containing computer randomized
individual allocations. This randomization will be carried out by research staff before the
initiation of the study. Information regarding basic demographic data, comorbidities that may
affect patient's perception of pain will be obtained from the subjects' chart. This
information will include: age, race, socioeconomic status, status of practitioner, parity,
BMI, history of prior cervical procedures, history of chronic pain.
If the subject has elected to participate in study and is randomized to the cold compression
group, she will have a cold compress placed on the abdomen five minutes prior to and
throughout the intrauterine device placement. Visual acuity pain scales have been commonly
used in similar studies to objectively assess procedural pain. In this study, a validated 10
point visual acuity scale will be used. Pain will be assessed pre- and post-procedure. The
post-procedure questions are directed at pain during the procedure.
Comparable studies that assess procedural pain considered a 30% reduction in pain to be
significant. Based on these studies we will similarly consider a 30% reduction in pain
between the experimental and control groups to be significant. With a power of 80 and
significance value of p < 0.05, this will require 69 patients in each group (cold compression
versus no-intervention) to obtain an adequate sample size to detect a difference in the
groups. The study was powered for the post-treatment means of the control groups to be 2.8
and 4.0 (respectively), which is a 30% difference, assuming a SD=2.8 and using a two-sample
t-test. Paper copies of written consent and any identifying information will be kept in a
secured, locked file. All data collected will be stored in a password protected computer file
that will be accessible only to the investigators.
The primary outcome will be the difference in patient's perception of pain before and during
intrauterine device insertion. This will be defined based on a pre and post-procedure survey
using a 10-point visual analogue scale. Additionally, nulliparous and multiparous women will
be stratified as previous studies have shown significantly different pain scores reported
between these two subgroups.
The investigators will collect the data, perform data entry and review charts to ensure
accuracy of information provided by the inserting physician. Periodic review of the data
entry will be performed to ensure completeness and accuracy.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT03686085 -
Vaginal Dinoprostone Administration Prior to a T380A Intrauterine Device Insertion in Nulliparous Women.
|
Phase 3 | |
Recruiting |
NCT05550064 -
Structured Contraceptive Counseling During Pregnancy
|
N/A | |
Recruiting |
NCT06179095 -
The Effect of Virtual Reality on Anxiety During Intrauterine Device Insertion
|
N/A | |
Completed |
NCT03383432 -
Intrauterine Device Insertion: a Step for High Satisfaction
|
N/A | |
Completed |
NCT03600064 -
Misoprostol for Cervical Ripening Before Copper Intrauterine Device Removal
|
N/A | |
Completed |
NCT05556421 -
Can Uterocervical Angle Predict the Displacement of Copper Intrauterine Devices (T-Cu 380A)
|
||
Completed |
NCT04045548 -
Vaginal Dinoprostone Administration Prior to Insertion Levonorgestrel-releasing Intrauterine System in Women With no Previous Vaginal Delivery
|
Phase 4 | |
Completed |
NCT03870711 -
10% Lidocaine Spray for Intrauterine Device Insertion
|
Phase 4 |